Ariad Pharmaceuticals Inc $7.20

up +0.11


17/4/2014 08:10 PM  |  NASDAQ : ARIA  
Industries : Drugs / Biotechnology
Get Trend Analysis Icon Get ARIA Trend Analysis - it has underperformed the S&P 500 by 81%

Partner Headlines

  1. Market Wrap For March 28: Markets Still Positive Despite Giving Up Early ...

    Benzinga
  2. Mid-Day Market Update: Restoration Hardware Surges On Earnings; Endocyte ...

    Benzinga
  3. Mid-Morning Market Update: Markets Open Higher; BlackBerry Reports Smaller-Than-Expected ...

    Benzinga
  4. Benzinga's Top #PreMarket Gainers

    Benzinga
  5. Morning Market Movers

    Benzinga
  6. Top Trending Tickers On StockTwits For March 14

    Benzinga
  7. Benzinga's Top Downgrades

    Benzinga
  8. Market Wrap For February 25: Markets End The Day Relatively Flat

    Benzinga
  9. Top Trending Tickers On StockTwits For February 25

    Benzinga
  10. Earnings Scheduled For February 25, 2014

    Benzinga
  11. You Can No Longer Ignore Biotech

    GuruFocus
  12. Credit Suisse Reports Ariad's Iclusig is 'Essential Drug'

    Benzinga
  13. Tug Of War In Ariad Pharmaceuticals

    Benzinga
  14. Benzinga's M&A Chatter for Monday January 27, 2014

    Benzinga
  15. Top Trending Tickers On StockTwits For January 27

    Benzinga
  16. Market Wrap For January 24: Fear Is Back In The Markets

    Benzinga
  17. Ariad Shares Continue to Surge Amidst Buyout Rumors

    Benzinga
  18. Ariad Pharnaceuticals Continues To Rally

    Benzinga
  19. Mid-Afternoon Market Update: Markets Get Hammered on China Fears as Microsoft ...

    Benzinga
  20. Top Trending Tickers On StockTwits For January 23

    Benzinga
  21. Benzinga's Top #PreMarket Gainers

    Benzinga
  22. Benzinga's M&A Chatter for Wednesday January 22, 2014

    Benzinga
  23. Market Wrap For January 17: Stocks Finish Week With Mixed Results

    Benzinga
  24. Top Trending Tickers On StockTwits For January 17

    Benzinga
  25. Benzinga's Top #PreMarket Gainers

    Benzinga
  26. Benzinga's Top #PreMarket Losers

    Benzinga
  27. UPDATE: JMP Securities Reiterates Coverage on ARIAD Pharmaceuticals, Sees ...

    Benzinga
  28. Market Wrap For January 6: Busy Day For Analysts Upgrades and Downgrades

    Benzinga
  29. UPDATE: Ariad Pharmaceuticals Downgraded by Citigroup

    Benzinga
  30. Benzinga's Top #PreMarket Losers

    Benzinga
  31. Benzinga's Top Downgrades

    Benzinga
  32. Market Wrap For January 2: Markets Begin 2014 on Negative Note

    Benzinga
  33. Mid-Afternoon Market Update: Markets Look to Close Red as Solar Stocks ...

    Benzinga
  34. Mid-Day Market Update: ANN Surges On Analyst Upgrade; DryShips Shares Decline

    Benzinga
  35. Mid-Morning Market Update: Markets Tumble; Fiat To Acquire Rest Of Chrysler

    Benzinga
  36. Benzinga's Top #PreMarket Gainers

    Benzinga
  37. ARIAD to Present at JP Morgan Healthcare Conference on Tuesday, January ...

    Benzinga
  38. Mid-Day Market Update: US Markets Turn Lower; Twitter Shares Fall On Analyst ...

    Benzinga
  39. Mid-Morning Market Update: Markets Mostly Higher; Textron To Acquire Beechcraft ...

    Benzinga
  40. UPDATE: Credit Suisse Raises PT on Ariad Pharmaceuticals, View Remains ...

    Benzinga
  41. UPDATE: Bank of America Reiterates on Ariad Pharmaceuticals Following News ...

    Benzinga
  42. UPDATE: Credit Suisse Reiterates on Ariad Pharmaceuticals as Iclusig Re-Launch ...

    Benzinga
  43. Benzinga's Top Upgrades

    Benzinga
  44. Benzinga's Top #PreMarket Gainers

    Benzinga
  45. Ariad to relaunch cancer drug

    IBD
  46. Mid-Day Market Update: Pep Boys Tumbles On Downbeat Results; Rambus Shares ...

    Benzinga
  47. UPDATE: Stifel Upgrades Ariad Pharmaceuticals on Physician Enthusiasm at ...

    Benzinga
  48. Mid-Morning Market Update: Markets Edge Lower; Toll Brothers Profit Tops ...

    Benzinga
  49. Benzinga's Top #PreMarket Gainers

    Benzinga
  50. Benzinga's Top #PreMarket Losers

    Benzinga
Trading Center